Department of Obstetrics and Gynecology St. Elizabeth’s Medical Center Boston, MA (USA) Education and Training: Undergraduate, University of Massachusetts, BS, Cum Laude, Biochemistry, 1986-90 Graduate, Albany Medical College, MD, 1992-96 Post Graduate, New England Medical Center, PGY-1 Obstetrics & Gynecology, 7/96-7/97 Post Graduate, New England Medical Center, Resident Obstetrics & Gynecology, 7/97-6/00 Appointments and Positions: Assistant Clinical Professor, Tufts University School of Medicine, 2000-present Caritas St. Elizabeth’s Medical Center, Student third year clinical rotation Coordinator, 2000-2003 Regis College, Nurse Practitioner program, Outpatient preceptor, 2007-present Certification and Licensure: Massachusetts State License #205483, 1996 American Board of Obstetrics and Gynecology, 2003 Membership In Professional Societies: American College of Obstetrics and Gynecology (Fellow), 2002-present Massachusetts Medical Society, 1998-present American Medical Society, 2005-present Academic Interests: Diagnosis and management of cervical disease St. Elizabeth’s Medical Center is devoted to women’s health care issues and welcomes projects related to safe motherhood from all over the world. Our residency program has residents from various countries and ethnic backgrounds. Our diversity is our strength.Read More
12 October, 2002 Mr. Paul Hoeffel Chief, NGO Section United Nations New York, NY 10017 Dear Sir: Please accept this letter of recommendation for the Women’s Health and Education Center of Springfield, Massachusetts. I have met with Dr. Rita Luthra on several occasions and understand the mission of the Center. It is my judgment that the Center is well qualified to be an accredited NGO to the DPI of the United Nations. Dr. Luthra has attended and participated in meetings of the UNA/USA and the Connecticut Division of our national organization. The Center is developing a useful and ambitious worldwide ob/gyn information system. If you have any questions, I would be pleased to respond. Sincerely, Irving Stolberg President, Connecticut Division UNA/USARead More
Professor of Obstetrics and Gynecology Chief, Division of Maternal-Fetal Medicine University of Utah Health Sciences Center (UUHSC) 30 North 1900 East SOM 2B200 Salt Lake City, UT 84132 (USA) Tel: 801-585-5156 Fax: 801-585-2594 E-mail: robert.silver@hsc.utah.edu Education and Training: INSTITUTION AND LOCATION DEGREE YEAR (s) FIELD OF STUDY University of Pennsylvania, Philadelphia, PA BA 1982 Microbiology Medical College of Pennsylvania, Philadelphia, PA MD 1986 Medicine University of Colorado Health Sciences Center, Denver, CO Residency 1986-1990 Obstetrics and Gynecology University of Utah Health Sciences Center (UUHSC), Salt Lake City, UT Fellowship 1990-1994 Maternal-Fetal Medicine A. Positions and Honors Positions 1990-1991 Clinical Instructor, Department of Ob/Gyn, UUHSC, SLC, UT 1992-1994 Instructor, Department of Ob/Gyn, UUHSC, SLC, UT 1994-1998 Assistant Professor, Department of Ob/Gyn, UUHSC, SLC, UT 1998-2006 Associate Professor with tenure, Department of Ob/Gyn, UUHSC, SLC, UT 2006-present Professor with tenure, Department of Ob/Gyn, UUHSC, SLC , UT 1995-2003 Residency Director, Department of Ob/Gyn, UUHSC, SLC, UT 2001-present Medical Director of Labor and Delivery, UUHSC, SLC, UT 2000-present Division Chief, Maternal Fetal Medicine, Department of Ob/Gyn, UUHSC, SLC, UT Honors 1985 Kurt Pauker Achievement Award for Excellence in Microbiology 1986 Alpha Omega Alpha 1993-1998 Research Scientist Development Program, National Institutes of Health 2000 Poster Award (best of session): IgA beta-2-glycoprotein-I Antibodies are Elevated in Women with Unexplained Recurrent Spontaneous Abortion and Unexplained Fetal Death, Society for Gynecologic Investigation 2001 Poster Award (best of session): Heparin-induced Thrombocytopenia is Rare in Pregnancy, Society of Perinatal Obstetricians 18th Annual Meeting 2003 Poster Award (best of meeting): Stillbirth in Utah from 1995-2001 B. Peer-Reviewed Publications Select peer-reviewed publications (in chronological order) Mitchell MD, Edwin SS, Lundin-Schiller S, Silver RM, Smotkin D, Trautman MS. (1993). Mechanism of interleukin-1 beta stimulation of human amnion prostaglandin biosynthesis: mediation via a novel inducible cyclooxygenase. Placenta 1993; 14:615-25. Edwin SS, Branch DW, Scott JR, Silver RM, Mitchell MD. Cyclosporin A attenuates increased prostaglandin and thromboxane production in response to various stimuli in human decidua. Am J Reprod Immunol 1993;30: 154-9. Silver RM, Draper ML, Scott JR, Lyon JL, Byrne SL, Ashwood EA, Branch DW. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: A harbinger of fetal death. Obstet Gynecol 1993; 83:150-5. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: An historical cohort study. Obstet Gynecol, 1994;83:372-7. Mitchell MD, LaMarche S, Adamson S, Coulam C, Silver RM, Edwin SS. Regulation of intrauterine prostaglandin biosynthesis interactions between protein kinase C and interleukin 1Β. Prost Leuk EFA 1994;50:137-40. Silver RM, Edwin SS, Trautmna MS, Simmons DL, Branch DW, Dudley DJ, Mitchell MD. Bacterial lipopolysaccharide mediated fetal death: Production of a newly-recognized form of inducible cyclooxygenase (COX-2) in murine deciduas in response to lipopolysaccharide. J Clin Invest 1995;93:725-31. Silver RM, Pierangelli SS, Gharavai AE, Harris EN, Edwin SS, Salafia CM, Branch DW. Induction of high levels of anticardiolipin antibodies in mice by immunization with Β2-glycoprotein 1 does not cause fetal death. Am J Obstet Gynecol 1995;173L1410-5. Silver RM, Porter TF, van Leeuwen I, Coulam C, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: Clinical consequences of low titers. Obstet Gynecol 1996;87:494-500. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489-93. Edwin SS, Branch DW, Scott JR, Silver RM, Dudley DJ, Mitchell MD. Cyclosporin A inhibits prostaglandin E2 production by fetal amnion cells in response to various stimuli. Prostaglandins 1996;52:51-61. Branch DW, Silver RM. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus 1996;5:409-13. Branch DW, Silver RM, Pierangeli SS, van Leeuwen I, Harris EN. Antiphospholipid antibodies other than lupus anticoagulant are not associated with recurrent pregnancy loss. Obstet Gyencol 1997;89:549-55. Silver RM, Edwin SS, Umar F, Dudley DJ, Branch DW, Mitchell MD. Bacterial lipopolysaccharide-mediate fetal death: The role of interleukin-1. Am J Obstet Gynecol 1997;176:544-9. Silver RM, Pierangeli SS, Edwin SS, Umar F, Harris EN, Scott JR, Branch DW. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who test negative for lupus anticoagulant and anticardiolipin antibodies. Am J Obstet Gynecol 1997;176:628-33. Silver RM, Smith LA, Edwin SS, Oshiro BT, Scott JR, Branch DW. Variable effects of immunoglobulin G fractions from women with antiphospholipid antibodies on murine pregnancy. Am J Obstet Gynecol 1997;177:229-33. Coulam CB, Clark DA, Beer AE, Kutteh WH, Silver RM, Kwad J, Stephenson M. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1997;38:57-74. Edwin SS, Mitchell MD, Silver RM, Branch DW, Dudley DJ. Ceramide stimulates prostaglandin production by human amnion and decidual cells J Soc Gynecol Invst 1997;4:274-8. Gharavi AE, Cucurull E, Tang H, Silver RM, Branch DW. Effect of antiphospholipid antibodies on beta-2-glycoprotein I-phospholipid interaction. Am J Reprod Immunol 1998;39:310-5. Kutteh WH, Rote NS, Silver RM. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol 1999;41:133-154. Pregnancy loss study group (Branch DW, Druzin M, El-Sayed Y, Esplin MS, Hrager J, Peaceman AM, Silver RK, Silver RM, Spinnato J). A multicenter, controlled, pilot study of intravenous immune globulin treatment antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 2000;182:122-7. Van-Horn JT, Craven C, Ward K, Branch DW, Silver RM. Histologic features of gestational tissues from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 2004;25:642-8. Ornoy A, Chen L, Silver RM, Mosmann TR, Miller RK. Maternal autoimmune diseases and immunologically-induced embryonic and feto-placental damage. Birth Defects Res Part A Clin Mol Teratol 2004;70:71-81. Frias AE, Luikenaar RA, Sullivan AE, Porter TF, Branch DW, Silver RM. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 2004;104:521-6. Sullivan AE, Silver RM, LaCoursiere DY, Porter TF, Branch DW. Does recurrent aneuploidy contribute to recurrent miscarriage? Obstet Gynecol 2004;10:784-8. Sullivan AE, Nelson L, Rice JA, Porter TF, Branch DW, Silver RM. The factor V Leiden and the G20210A prothrombin gene mutations are rare in women with fetal death. Am J Reprod Immunol 2005;54;1-4. Sullivan AE, Nelson L, Silver RM, Frias AE, Porter TF, Branch DW. The aryl hydrocarbon receptor nuclear tranlsocator gene polymorphism in patients with recurrent miscarriage. Am J Reprod Immunol 2006;55(1): 51-3 Silver RM, Landon MB, Rouse DC, Leveno JK, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107(6): 1226-32. Silver RM. Fetal Death. Obstet Gynecol 2007;109(1):153-67. Silver RM, Varner MW, Reddy U, Goldenberg R, Pinar H, Conway D, Bukowski R, Carpenter M, Hogue C, Willinger M, Dudley D, Saade G, Stoll B. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol 2007;196:433-44. Warren JE, Silver RM, Nelson L, Dalton J, Porter TF, Branch DW. Cervical insufficiency: a genetic condition? Collagen 1?1 intron SP1 and transforming growth factor-? ARG-25-PRO polymorphisms in women with cervical insufficiency. Obstet Gynecol 2007;110:619-24. Raju TN, Nelson KB, Ferriero D, Lynch JK; NICHD-NINDS Perinatal Stroke Workshop Participants. Pediatrics 2007;120:609-16. Holmgren C, Esplin MS, Hamblin S, Esplin MS, Molenda M, Silver RM. Evaluation of the use of anti-TNF-alpha in an LPS-induced murine model. J Reprod Immunol 2008; Epub, April 21. Silver RM. New anticoagulants and pregnancy. Obstet Gynecol 2008;112:419-20. Silver RM. Immune activation early in pregnancy: trouble down the road. Am J Obstet Gynecol 2008, 199;327-8. Holmgren C, Porter TF, Varner MW, Aagard K, Silver RM. Hyperemesis in pregnancy: A comparison of treatment strategies. Am J Obstet Gynecol, 2008;198:56e1-4. Turok DK, Gurtcheff S, Esplin MS, Shah M, Simonsen SE, Shah M, Trauscht-Van Horn J, Silver RM. Second trimester termination of pregnancy: A review by site and procedure type. Contraception 2008;77:155-61 Peltier MR, Faux DS, Hamblin SD, Cooper C, Silver RM, Esplin MS. Effect of aspirin treatment on TNF-? Production by women with a history of preterm birth. J Reprod Immunol 2009;80:109-14. Warren JE, Silver RM, Branch DW, Porter TF. Thromboprophylaxis and pregnancy outcomes in asymptomatic women with thrombophilias. Am J Obstet Gynecol 2009;200:281.e1-5. Warren JE, Nelson L, Esplin MS, Silver RM. Interleukin-10 polymorphisms and cervical insufficiency. Am J Obstet Gynecol 2009;201:372-4. Manuck TA, Eller AG, Esplin MS, Stoddard G, Varner MW, Silver RM. Outcomes of expectantly managed preterm premature rupture of membranes occurring ? 24 weeks gestation. Obstet Gynecol 2009;114:29-37. Reddy UM, Goldenberg R, Silver R, Smith GCS, Pauli RM, Wapner RJ, et al. Stillbirth classification: developing an international consensus for research: Executive summary of NICHD workshop. Obstet Gynecol 2009;114:901-14. Manuck TA, McLean, Varner MW, Silver RM. Preterm premature rupture of membranes: does the duration of latency influence neonatal outcome? Am J Obstet Gynecol 2009;201:414-6. Warren JE, Turok DK, Maxwell TM, Brothman AR, Silver RM. Array comparative genomic hybridization (aCGH) for genetic evaluation of fetal loss between 10 and 20 weeks gestation. Obstet Gynecol 2009;114:1093-1102. Clark EAS, Lacoursiere DY, Byrne JLB, Ponder R, Silver RM, Esplin MS. Reliability of fetal MCA velocity: a randomized controlled trial of sonographer training. J Ultrasound Med 2009;28:19-25. Grosvenor Eller A, Silver RM, Zempolich K, Soisson P, Simonson SE. Optimal management of placenta accreta. Br J Obstet Gynecol 2009;116:648-54. Peltier MR, Faux DS, Hamblin SD, Silver RM, Esplin MS. Cytokine production by peripheral blood mononuclear cells of women with a history of preterm birth. In press, J Reprod Immunol. Silver RM, Zhao Y, Spong C, Caritis SN, Sibai B, Wendel G Jr., et al. Prothrombin gene G20210A mutation and obstetric complications: a prospective cohort. In press, Obstet Gynecol. C. Research Support Ongoing Support NIH/NICHD 1U10HD063053-01 Preterm Birth in Nulliparous Women: An Understudied Population (Silver)12/01/2009-11/30/2014 This Network will design and execute a prospective, longitudinal cohort study of 10,000 nulliparous women. The research protocols developed will determine characteristics that influence and/or predict adverse pregnancy outcomes in nulliparous women including genetics, epigenetics, physiological response to pregnancy, interaction with environmental exposures, fetal growth and development, and placental development and function. Role: PI NIH/NICHD 3U10HD045944-05S2 Research on the Scope and Causes of Stillbirth in the United States (Silver)09/26/2003—07/31/2009NCX The major goals of this project are to develop a network of collaborating academic centers to study the extent and causes of stillbirth and to develop methods for stillbirth prevention. Role: PI NIH/NICHD HHSN267200603423C / N01DK63423 (Silver)09/30/2006-09/29/2011 The Effects of Aspirin in Gestation and Reproduction The purpose of this contract is to evaluate the effect of daily low-dose aspirin on all phases of reproduction beginning at preconception and continuing throughout pregnancy, including implantation and live births. Role: PIRead More
President, Royal College of Obstetricians and Gynaecologists (RCOG), 2013-2016 27 Sussex Place Regent’s Park London NW1 4RG; U.K. T: +44 20 7772 6250 David is a consultant uro-gynaecologist at the Liverpool Women’s Hospital and was its Medical Director for 17 years from 1993 to 2010 prior to becoming Vice President (Clinical Quality) of the RCOG. During his tenure he published High Quality Women’s Health (2011)–a proposal for developing a public health life-course approach to care combined with implementing networks for delivery. He championed the production of the first RCOG national Maternity Clinical Indicators Report for England. This will act as a template for further national reports to include other aspects of clinical performance. David has promoted clinical quality initiatives and audit at a national level and encouraged the College to develop quality improvement projects (Each Baby Counts and Perineal Trauma – 2015). His main interests lie in all aspects of education, training, clinical quality and safety and the implementation of national guidance. He has a strong track record in workforce planning and authored the RCOG report on the Future Workforce in Obstetrics and Gynaecology for England and Wales (2009). This has led to a working party to review national standards for maternity care and also gynaecology with a particular emphasis on service delivery; Safer Women’s Healthcare. Dr. Richmond has been keen to improve the relationship between the College and its membership and is implementing the recommendations of its Governance Review and subsequent Representation Working Party which has proposed greater openness and transparency of College working and Council meetings. He has also opened the discussion on increasing the electorate to its members potentially on a global footing. He is Vice Chair of the Academy of Medical Royal Colleges and Council member and Fellow of the Faculty of Medical Leadership and Management. He has developed strong links with the UK Government ministers in areas of mutual benefit, the Care Quality Commission and NHS England. David has represented the RCOG on independent national reviews in Scotland and England with regard to surgical mesh use for incontinence and prolapse and is co-chair of the models of care stream in the NHS Maternity Review. His main interests outside medicine involve his family and the outdoors including his garden, golf, running and climbing.Read More
16 February, 1994 Dear Dr. Luthra, On behalf of the IYF Coordinator, I would like to acknowledge, with thanks, receipt of your letter to him of 9 February 1994. We are very pleased to learn that you have established close contacts with Dr. Belsey of WHO and have made good progress on your plans and activities on health and status of women in developing countries, as a specific contribution to the International Year of the Family. The IYF Coordinator and his Secretariat will continue to be of assistance whenever possible. As regards the proposed dates for the conference on the Year, kindly note that a major international event is planned to be held in Montreal from 12 to 15 October, held in cooperation with the IYF Secretariat, and on 18 October the General Assembly is scheduled to hold a special conference on families. I am attaching, by fax, relevant pages of the Calendar of events related to the Year, which you may find useful in your planning. A copy of the Calendar is sent by mail. I look forward to our continued and mutual beneficial cooperation. With best wishes, Yours sincerely, George Puthuppally Social Affairs OfficerRead More
President Women’s Health and Education Center (WHEC) NGO in Special Consultative Status with the Economic and Social Council of the United Nations e-mail: Rita@WomensHealthSection.com Dr. Rita Luthra is President of The Women’s Health and Education Center (WHEC) which is NGO (non-governmental organization) in Special Consultative Status with the Economic and Social Council of the United Nations. It is also affiliated with the World Health Organization (WHO), PMNCH (Partnership for Maternal and Child Health at WHO), The Economic and Social Council (ECOSOC), UN Department of Public Information ( UN DPI), UN Women, UN University (UNU), UN Foundation (UNF), and Every Woman Every Child Global Strategy initiative of the UN Secretary-General. Established in 2001, The Women’s Health and Education Center (WHEC) undertakes initiatives with the United Nations (UN) and the World Health Organization (WHO), to achieve the hopes and dreams of Sustainable Development Goals (SDGs), with special focus on Maternal and Child Health. Dr. Luthra has worked with various international organizations, such as the UNA-USA, Peace Corps, Population Council and World Health Organization. Dr. Luthra’s main interest is international health and development. She has 25 years of expertise in the project/program development at the National and International levels with various respectable international organizations, and innovative health technology systems such as telemedicine, online distance education and various e-Health management systems. The use of information science and telecommunications to support the practice of medicine when distance separates the caregiver from the patient is the way forward to make medical care more affordable and more accessible in every country. A strong and vital health workforce is an investment in health for today and the future. It has profound effect on all the citizens of the world, political, social, and economic systems. There are 3 leading purposes of the health-related uses of information and communication technologies (ICT) in low- and middle-income countries: To extend geographic access to health care; To improve data management; and To facilitate communication between patients and physicians outside the physician’s office. In 2018 at High Level Political Forum (HLPF), Dr. Luthra presented WHEC Global Health Line’s (WGHL’s) LINK (Learning and Innovation Network for Knowledge Solutions) Access Project — To provide access to reproductive health research worldwide, at UN Headquarters, NYC, New York (USA). Available @ UN Web TV: http://webtv.un.org/watch/player/5807660229001 Dr. Luthra was born and grew up in Rajasthan, India and currently resides in Massachusetts, USA. She received her education and medical degree (Bachelor of Medicine and Bachelor of Surgery) M.B.B.S. from University of Rajasthan, Jaipur (India) in 1974. M.D. (Doctor of Medicine) in Obstetrics and Gynecology, in 1978 from The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh (India). After finishing the residency in Obstetrics and Gynecology at St. Elizabeth’s Medical Center, Boston, MA (USA) she received Fellowship in Obstetrics and Gynecology from the American College of Obstetrics and Gynecology, in 1986. She practiced Obstetrics and Gynecology mostly in Massachusetts (USA) till November 2015. Currently working with the UN and WHO on various initiatives to achieve Universal Health Care (UHC) and improve maternal and child health. Dr. Luthra is Editor-in-Chief of the e-learning publications: http://www.WomensHealthSection.com and WHEC Update. The initiatives of WHEC are also posted on CSO Net (Civil Society Net) under Best Practices and Projects on World Map ID # 364, title: Continuing Medical Education for the Globalized World. http://www.WomensHealthSection.com — knowledge that touches patients, is a vision for the globalized world. Please visit our Letters of Support Page: http://www.womenshealthsection.com/whec/letters We welcome everyone. Dedicated to Women’s and Children’s Healthcare and Wellbeing WorldwideRead More
UN Solution Summit; Global Innovation Exchange— 07 2019 THE WHITE HOUSE; President Donald J. Trump— 29 November 2018 THE WHITE HOUSE; President Donald J. Trump— 13 November 2018 UNDPINGO — Invitation & RSVP — Tuesday Chat Series, End Child Marriage2:30 — 4:00 PMDPI NGO Resource Center801 UN Plaza, 2nd Floor,New York, NY 10017— 17 April 2018 Economic and Social Council (ECOSOC); United Nations Commission on Populationand Development; E/CN.9/2018/NGO/2— January 2018 THE WHITE HOUSE; President Trump— January 2018 United Nations; Secretary General António Guterres— January 2018 THE WHITE HOUSE; Holiday Greetings, President Trump and First Lady Melania Trump— January 2018 UN Documents, DPI-NGO-Announcements-Page-4— February 2017 THE WHITE HOUSE; Holiday Greetings, President Obama and First Lady Michelle Obama— January 2017 WHEC Commitment to Every Woman Every Child— November 2016 WORLD HEALTH ORGANIZATION; Dr. Flavia Bustreo, Assistant Director-General, Family, Women’s and Children’s Health— August 2016 THE WHITE HOUSE; President Obama— July 2016 UN Partnerships For SDGs: WHEC Initiative Statement— July 2016 Statement to the UN Economic and Social Council — E/2015/NGO/2— May 2015 UNITED NATIONS; Secretary-General of the United Nations BAN Ki-moon— December 2014 THE WHITE HOUSE; Holiday Greetings, President Obama and First Lady Michelle Obama— December 2014 Statement to the UN Economic and Social Council — E/2014/NGO/53— May 2014 UN Secretary General’s Acknowledgement— December 2013 Yale OFFICE OF THE PRESIDENT— October 2013 UN Secretary General’s Acknowledgement— December 2012 UN Secretary General’s Acknowledgement— December 2011 Analysing Commitments to Advance the Global Strategy for Women’s and Children’s Health: — The PMNCH 2011 Report— December 2011 UN Secretary General’s Invitation — Every Woman Every Child — The Effort to Advance the Global Strategy— September 2011 Partnership for Maternal, Newborn & Child Health (World Health Organization) – PMNCH Member— Since May 2011 CSO Net, ECOSOC Civil Society Network: Projects on World Map— December 2009 UN-NGO-IRENE Best Practices Network: Continuing Medical Education Initiative for the Globalized World— 30 March 2009 WHO | e-Learning Publication: WomensHealthSection.com— 2008 NGO SECTION, DESA: Special Consultative Status granted— July 2008 (pdf) NGO Section, DESA: Recommendation to Special Consultative Status— June 2008 (pdf) DPI-NGO Letter of Association— June 2008 (pdf) Letter of Academic Partnership Unit of UN— February 2008 WORLD HEALTH ORGANIZATION— November 2007 UNITED NATIONS— October 2007 Bulletin of the World Health Organization— November 2006 (pdf) Sign Out: Insights and reflections from thought leaders in Obstetrics and Gynecology — Contemporary OB/GYN— September 2006 Department of Public Information, Non-Governmental Organizations (DPI-NGO)— 23 June 2006 United Nations University— 7 December 2005 UNITED NATIONS— 25 August 2005 UNITED NATIONS— 29 July 2005 WORLD HEALTH ORGANIZATION— 1 July 2005 (pdf) Department of Public Information, Non-Governmental Organizations (DPI-NGO)— 7 April 2005 UNITED NATIONS— 23 February 2005 United Nations Educational, Scientific and Cultural Organziation (UNESCO)— 9 November 2004 WORLD HEALTH ORGANIZATION— 25 October 2004 The Executive Committee of Non-Governmental Organizations Associated with the United Nations Department of Public Information— 8 January 2004 UNITED NATIONS— 30 June 2003 British Journal of Anesthesia— 2003, Barclay 90 (6): 816 (pdf) Postgraduate Institute Of Medical Education And Research, Chandigarh -160 012 (India)— 27 November 2002 American College of Obstetricians and Gynecologists— 15 November 2002 United Nations Association of the United States of America and the Business Council for the United Nations— 12 October 2002 UNITED NATIONS Department for Policy Coordination and Sustainable Development— 16 February 1994 Эта страница содержит документы в формате PDF. Вам понадобится Adobe Reader для просмотра этих документов.Read More
Senior Advisor in Health Promotion Leader, Urban Health and Health Determinants Team Area for Sustainable Development and Environmental Health Pan American Health Organization (PAHO) 525 23rd Street, NW Washington, DC 20037 Phone: 202 974-3969 Fax: 202 974-3645 e-mail: ricemari@paho.org Marilyn Rice is Senior Advisor in Health Promotion and Coordinator of the Urban Health and Determinants of Health Team for the Area of Sustainable Development and Environmental Health for the Pan American Health Organization (PAHO/WHO). She has over 30 years of experience working in a multi-cultural, multi-lingual environment, often playing the role of a facilitator to help ensure clear communication and collaborative efforts in developing and implementing initiatives. She has done extensive work to support systematic evaluation and documentation of health education and promotion experiences in countries throughout the world and she coordinated and oriented technical cooperation activities in the areas of health promotion, social determinants of health, urban health and development, community mobilization, and implementation of healthy public policies. She has worked for PAHO for 22 years and the Global Office of the World Health Organization (WHO) for 7. She has also held the position of Project Director of the National Resource Center for Prevention of Perinatal Abuse of Alcohol and Other Drugs and Branch Chief of the Perinatal Branch for the US Center for Substance Abuse Prevention (part of the US Department of Health and Human Services). She holds a degree in sociology and masters training in public health and health education. She is known throughout the world for her work in community development, social mobilization, health promotion and education, as well as for her leadership in the emerging field of urban health. She has been very active in the International Union for Health Promotion and Education (IUHPE), serving multiple terms as Regional Director, and she currently is the Regional Vice President for the North American Regional Office (NARO) and sits on the Global and NARO Boards. Additionally, she is the Chair of Society of Public Health Education’s (SOPHE) International and Cross-Cultural Health (ICCH) Community of Practice and as a result she also sits on the SOPHE Board. She is on the editorial board of numerous peer review journals in the fields of health promotion and education. More specifically, Marilyn Rice’s experience includes: Extensive experience in leading and managing the design and monitoring of new projects through promoting team work with a diverse group of professionals, and developed long-range strategies and objectives through consensus-building in initiatives focused on but not limited to the following areas: maternal and child health; reproductive health and family planning; gender sensitive health and development initiatives; demonstration projects addressing pregnant and postpartum women and infants exposed to alcohol and other drugs; participatory action planning and evaluation in health promotion and education, especially in local development priorities and in reproductive health; nutrition education; participatory education in health; research projects in health promotion/education and community participation, and in alcohol and other drug use; school-based health education; and disaster preparedness and the community’s participation Creating strategies, analytical models and methodologies for the planning and evaluation of public health initiatives Providing technical assistance and advice to countries throughout the world Writing state-of-the-art documents and guidelines in techniques for planning, implementing, monitoring and evaluating programs Developing training manuals and materials from entire face to face and virtual courses to supplemental electronic teaching and audio visual materials Drafting and securing approval from the Ministers of Health from countries throughout the Americas for position papers, as well as resolutions to generate cooperative implementation of PAHO and WHO programs by these governments Coordinating collaboration with a diverse group of professionals from United Nations, intra-country, national, regional and local agencies, universities, schools of public health, community organizations and professional societies Delivering numerous public speeches, presentations, briefings, lectures and seminars to audiences — in English, Spanish, Portuguese and French for government officials and/or for community leadersRead More
